Rankings
▼
Calendar
SBFM FY 2023 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena
SBFM
Sunshine Biopharma, Inc.
$6M
FY 2023 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$24M
+454.4% YoY
Gross Profit
$8M
34.6% margin
Operating Income
-$5M
-19.9% margin
Net Income
-$5M
-18.7% margin
EPS (Diluted)
$-351.36
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$10M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$27M
Total Liabilities
$6M
Stockholders' Equity
$21M
Cash & Equivalents
$16M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$24M
$4M
+454.4%
Gross Profit
$8M
$2M
+391.4%
Operating Income
-$5M
-$27M
+82.3%
Net Income
-$5M
-$27M
+83.2%
← Q4 2022
All Quarters
Q1 2023 →